{"schema_version":"secwatch.filing_event.v1","accession":"0001829126-26-004744","form_type":"8-K","ticker":"KALA","cik":"0001479419","company_name":"KALA BIO, Inc.","filed_at":"2026-05-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.343653+00:00","generated_at":"2026-05-14T21:35:44.519481+00:00","sec_items":["3.03","5.03","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"confidence":"high","headline":"KALA BIO announces 1-for-50 reverse stock split effective May 8, 2026","bullets":["Reverse stock split at 1-for-50 ratio effective 4:05 p.m. ET on May 8, 2026.","Outstanding shares reduced from 929,491,578 to ~18,589,832; no fractional shares issued.","Cash paid for fractional shares based on May 7 closing price on Nasdaq Capital Market.","Ticker KALA unchanged; split-adjusted trading begins May 11, 2026; new CUSIP 483119301.","Stockholder approved reverse split at January 30, 2026 annual meeting with ratio range of 1-for-2 to 1-for-100."],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-26-004744","json":"https://secwatch.observer/filing/0001829126-26-004744.json","markdown":"https://secwatch.observer/filing/0001829126-26-004744.md","text":"https://secwatch.observer/filing/0001829126-26-004744.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1479419/000182912626004744/0001829126-26-004744-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1479419/000182912626004744/kalabio_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-14T21:35:44.519481+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}